AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 278: F628-F634, 2000;
0363-6127/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (42)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, D. C.
Right arrow Articles by Ziyadeh, F. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, D. C.
Right arrow Articles by Ziyadeh, F. N.
Vol. 278, Issue 4, F628-F634, April 2000

Therapy with antisense TGF-beta 1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice

Dong Cheol Han, Brenda B. Hoffman, Soon Won Hong, Jia Guo, and Fuad N. Ziyadeh

Renal-Electrolyte and Hypertension Division and Penn Center for Molecular Studies of Kidney Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6144

Inhibition of gene expression by antisense oligodeoxynucleotides (ODNs) relies on their ability to bind complementary mRNA sequences and prevent translation. The proximal tubule is a suitable target for ODN therapy in vivo because circulating ODNs accumulate in the proximal tubule in high concentrations. Because increased proximal tubular transforming growth factor- beta 1 (TGF-beta 1) expression may mediate diabetic renal hypertrophy, we investigated the effects of antisense TGF-beta 1 ODN on the high-glucose-induced proximal tubular epithelial cell hypertrophy in tissue culture and on diabetic renal hypertrophy in vivo. Mouse proximal tubular cells grown in 25 mM D-glucose and exposed to sense ODN as control (1 µM) exhibited increased 3[H]leucine incorporation by 120% and total TGF-beta 1 protein by 50% vs. culture in 5.5 mM D-glucose. Antisense ODN significantly decreased the high-glucose-stimulated TGF-beta 1 secretion and leucine incorporation. Continuous infusion for 10 days of ODN (100 µg/day) was achieved via osmotic minipumps in diabetic and nondiabetic mice. Sense ODN-treated streptozotocin-diabetic mice had 15.3% increase in kidney weight, 70% increase in alpha 1(IV) collagen and 46% increase in fibronectin mRNA levels compared with nondiabetic mice. Treatment of diabetic mice with antisense ODN partially but significantly decreased kidney TGF-beta 1 protein levels and attenuated the increase in kidney weight and the alpha 1(IV) collagen and fibronectin mRNAs. In conclusion, therapy with antisense TGF-beta 1 ODN decreases TGF-beta 1 production and attenuates high-glucose-induced proximal tubular cell hypertrophy in vitro and partially prevents the increase in kidney weight and extracellular matrix expression in diabetic mice.

transforming growth factor-beta 1; nephropathy; proximal tubule; glucose; collagen type IV; fibronectin; osmotic mini-pumps


This article has been cited by other articles:


Home page
HypertensionHome page
B. Shen, M. Hagiwara, Y.-Y. Yao, L. Chao, and J. Chao
Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress
Hypertension, May 1, 2008; 51(5): 1358 - 1365.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y.-C. Tian, D. Fraser, L. Attisano, and A. O. Phillips
TGF-{beta}1-mediated alterations of renal proximal tubular epithelial cell phenotype
Am J Physiol Renal Physiol, July 1, 2003; 285(1): F130 - F142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. J. Dahly, K. M. Hoagland, A. K. Flasch, S. Jha, S. R. Ledbetter, and R. J. Roman
Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R757 - R767.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. A. Eddy
Plasminogen activator inhibitor-1 and the kidney
Am J Physiol Renal Physiol, August 1, 2002; 283(2): F209 - F220.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S.-L. Zhang, C. To, X. Chen, J. G. Filep, S.-S. Tang, J. R. Ingelfinger, and J. S. D. Chan
Essential Role(s) of the Intrarenal Renin-Angiotensin System in Transforming Growth Factor-{beta}1 Gene Expression and Induction of Hypertrophy of Rat Kidney Proximal Tubular Cells in High Glucose
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 302 - 312.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Hua, H. J. Goldberg, I.G. Fantus, and C. I. Whiteside
High Glucose-Enhanced Mesangial Cell Extracellular Signal-Regulated Protein Kinase Activation and {alpha}1(IV) Collagen Expression in Response to Endothelin-1: Role of Specific Protein Kinase C Isozymes
Diabetes, October 1, 2001; 50(10): 2376 - 2383.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
M. Zeisberg, G. Bonner, Y. Maeshima, P. Colorado, G. A. Muller, F. Strutz, and R. Kalluri
Renal Fibrosis : Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation
Am. J. Pathol., October 1, 2001; 159(4): 1313 - 1321.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
A. S. D. VRIESE, R. G. TILTON, M. ELGER, C. C. STEPHAN, W. KRIZ, and N. H. LAMEIRE
Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes
J. Am. Soc. Nephrol., May 1, 2001; 12(5): 993 - 1000.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
M. ISONO, M. C. I.-D. L. CRUZ, S. CHEN, S. W. HONG, and F. N. ZIYADEH
Extracellular Signal-Regulated Kinase Mediates Stimulation of TGF-{beta}1 and Matrix by High Glucose in Mesangial Cells
J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2222 - 2230.
[Abstract] [Full Text]


Home page
QJMHome page
A.O. Phillips
Diabetic nephropathy--where next?
QJM, October 1, 2000; 93(10): 643 - 646.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. H. Park and H. J. Han
The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells
Am J Physiol Renal Physiol, February 1, 2002; 282(2): F228 - F237.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online